61. FGF-20 And DKK1 Are Transcriptional Targets Of [beta]-catenin And FGF-20 Is Impl harold E varmus, Cancer Biology and Genetics Program, SloanKettering Institute,varmus Laboratory-RRL717, Memorial Sloan-Kettering Cancer Center, http://www.nature.com/emboj/journal/v24/n1/abs/7600460a.html

@import "/emboj/style_article.css"; SEARCH: Advanced search MY ACCOUNT E-ALERTS SUBSCRIBE REGISTER ... Contact Editorial office Customer services Subscribe Order sample copy Contact NPG Advertising ... www.embo.org Subject Categories: Signal Transduction Molecular Biology of Disease The EMBO Journal Published online 9 December 2004 FGF-20 and DKK1 are transcriptional targets of -catenin and FGF-20 is implicated in cancer and development Mario N Chamorro , Donald R Schwartz , Alin Vonica , Ali H Brivanlou , Kathleen R Cho and Harold E Varmus Cancer Biology and Genetics Program, Sloan-Kettering Institute, Varmus Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI, USA The Laboratory of Vertebrate Embryology, The Rockefeller University, New York, NY, USA Cell Biology Program, Cornell University, Weill Graduate School of Medical Sciences, New York, NY, USA To whom correspondence should be addressed Harold E Varmus, Cancer Biology and Genetics Program, Sloan-Kettering Institute, Varmus Laboratory-RRL717, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 62, New York, NY 10021, USA. Tel.: +1 212 639 6561; Fax: +1 212 717 3125; E-mail: varmus@mskcc.org

62. Letter To The Director Of The NIH: Serious Breaches harold E. varmus, MD Director National Institutes of Health 9000 Rockville PikeBethesda, MA 20892. March 20, 1998. Dear Dr. varmus,. As an AIDS activist, http://tmh.floonet.net/articles/varmus.shtml

Topics [Click on radio buttons or press assigned key with Ctrl (Mac) or Alt (Win)] [a] Individualist Anarchism [b] Philosophical Egoism [c] Other Egoist Sites [d] More Anti-Statism [e] Anarchism and Feminism [f] Anti-war Propaganda [g] Civilian-Based Defense [h] Major anarchist resources on the web [i] Libertarianism, etc. on the web [j] The "Austrian School" of Economics [k] The Loyal Opposition [l] The HIV=AIDS Controversy [m] Thoughts of School [n] Odd Bins [o] Search Engines From the archives of The Memory Hole HIV=AIDS Controversy: The Hand in the Till Department A letter to the director of the National Institutes of Health, Dr. Harold E. Varmus, from a concerned U.S. citizen regarding the questionable doings of one of the director's high profile underlings. This letter to Dr. Varmus was officially posted to misc.health.aids by W. Fred Shaw ( fredshaw@primenet.com ) on 27 March 1998. Harold E. Varmus, M.D. Director National Institutes of Health 9000 Rockville Pike Bethesda, MA 20892 March 20, 1998 Dear Dr. Varmus, As an AIDS activist, I am notifying you of serious breaches of ethical guidelines by the Director of the National Institute of Allergy and Infectious Disease (NIAID), Dr. Anthony Fauci, M.D. This complaint isn't about personalities or superficial public perceptions, but rather something much more insidious: an institutional breakdown in ethics that has concentrated far too much power, authority and blind trust in the hands of a single individual, Dr. Anthony Fauci. Without any doubt, the facts will prove that Dr. Fauci has broken the rules, Dr. Fauci has violated our trust and Dr. Fauci has compromised the most fundamental principles of scientific ethics and integrity.

63. October 19, 1999 Letter From NIH Director, Dr. Harold Varmus To Ralph Nader, Jam Dr. harold E. varmus Building 1, 126 National Institutes of Health Bethesda,Maryland 20892. James Love Consumer Project on Technology http://www.cptech.org/ip/health/sa/varmusletteroct19.html

October 19, 1999 letter from NIH Director, Dr. Harold Varmus to Ralph Nader, James Love and Robert Weissman responding to their request calling on the NIH to provide the World Health Organization, WHO, access to US government funded medical inventions. (Ralph Nader, James Love and Robert Weissman each received separate letters.) Dr. Harold E. Varmus Building 1, 126 National Institutes of Health Bethesda, Maryland 20892 James Love Consumer Project on Technology P.O. Box 19367, Washington, DC 20036 Dear Mr. Love: Thank you for your recommendations on how the National Institutes of Health (NIH) could interact with the World Health Organization (WHO) to provide it with commercial development rights to NIH-owned and -funded health care patents. As we are both aware, the licensing of Government inventions has received much attention in recent months from Members of Congress, patient advocacy groups, representatives of industry and the press. The public debate has been galvanized by concerns about the AIDS crisis in developing countries and the role of anti-AIDS therapeutic drugs in addressing that crisis. This proposal, if implemented, would have powerful repercussions on the current framework for drug development arising from federally supported basic research. I am concerned that your proposal that the NIH employ its "Government use" license authorities to grant WHO standing authority to contract for the production of Government-supported inventions so as to make anti-AIDS drugs available for less cost than offered by pharmaceutical manufacturers would put the current system at risk without necessarily resulting in greater accessibility to these drugs. I am also troubled by the implications of the NIH intervening on behalf of sovereign foreign governments in a situation in which many of those governments have the authority to achieve the same result and in which U.S. intervention on this matter has not been requested.

64. September 3, 1999 Letter From Ralph Nader, James Love, Robert Weissman To Dr. Ha Dr. harold E. varmus Building 1, 126 National Institutes of Health Bethesda,Maryland 20892. We are writing to ask that you enter into an agreement with the http://www.cptech.org/ip/health/sa/varmus-sep99.html

September 3, 1999 letter from Ralph Nader, James Love, Robert Weissman to Dr. Harold Varmus, Director of NIH, asking for NIH to give the World Health Organization, WHO, access to US government funded medical inventions. Ralph Nader P.O. Box 19312, Washington, DC 20036 James Love Consumer Project on Technology P.O. Box 19367, Washington, DC 20036 http://www.cptech.org Robert Weissman Essential Action P.O. Box 19405, Washington, DC 20036 http://www.essentialaction.org/ September 3, 1999 Dr. Harold E. Varmus Building 1, 126 National Institutes of Health Bethesda, Maryland 20892 We are writing to ask that you enter into an agreement with the World Health Organization (WHO), giving the WHO the right to use health care patents that the US government has rights to under 35 USC Sec 202 (c)(4) of the Bayh-Dole Act or under 37 CFR 404.7, for government owned inventions. Under the regulations concerning government owned inventions, the US government has an:

65. The Johns Hopkins Gazette May 18, 1998 harold E. varmus, director of the National Institutes of Health. harold varmushas been since 1993 the director of the National Institutes of Health, http://www.jhu.edu/~gazette/aprjun98/may1898/18speaks.html

May 18, 1998 VOL. 27, NO. 35 Ten Ceremonies To Mark The End Of Hopkins' 122nd Academic Year At a university-wide commencement ceremony beginning at 9:30 a.m. on Thursday, May 21, in the Gilman Quadrangle at Homewood, President William R. Brody will confer an estimated 4,865 degrees on Johns Hopkins students, marking the end of the university's 122nd academic year. Diplomas await Commencement Day in the Registrar's Office. Brody, who took office as Hopkins' 13th president on Aug. 26, 1996, will deliver the address. The nine other diploma ceremonies (see schedule below) will feature their own speakers, some of whom are profiled here. Arts and Sciences and Engineering Undergraduate Ceremony: Elizabeth Dole, president of the American Red Cross Elizabeth Dole, who will receive an honorary degree in recognition of her public service, is a native of Salisbury, N.C., and graduated with distinction from Duke University, where she was elected to Phi Beta Kappa. She received her law degree from Harvard University, from which she also holds a master's degree in education and government. [For details of her career, see the May 18 Gazette story: "University to recognize six with honorary degrees School of Hygiene and Public Health: Harold E. Varmus, director of the National Institutes of Health

66. Will NIH Ban On Consulting Deals With Drug Firms Set An Ethical Example? LAT / N when thenagency Director harold E. varmus quietly lifted a range of restrictions varmus allowed all NIH employees - including institute and center http://www.ahrp.org/infomail/05/02/02a.php

Search About AHRP / Mission Statement What's New AHRP Infomails ... Links Alliance for Human Research Protection AHRP is a national network of lay people and professionals dedicated to advancing responsible and ethical medical research practices, to ensure that the human rights, dignity and welfare of human subjects are protected, and to minimize the risks associated with such endeavors. Will NIH Ban on Consulting Deals with Drug Firms Set an Ethical Example? LAT / NYT Wed, 2 Feb 2005 The Los Angeles Times, whose investigative reports about conflicts of interest at the National Institutes of Health, shook the foundations of NIH by prying open the vaults that contained secret deals between NIH scientists and the drug and biotech industry, resulted in a ban on all financial ties between NIH staff and the drug and biotech industry. Today the LAT reports that NIH director Dr. Elias Zerhouni "suggested that the seeds of the NIH's difficulties with conflict of interest were sown in 1995, when then-agency Director Harold E. Varmus quietly lifted a range of restrictions on moonlighting in the industry. Varmus allowed all NIH employees - including institute and center directors - to enter into deals with drug companies and to accept stock and stock options as compensation." Given Dr. Zerhouni's year long resistence to ending conflicts of interest at the NIH - as he derided calls for complete bans as "ivory tower" proposals "that flew in the face of the agency's need to work toward cures" - both he and Dr. Varmus reflect the same culture. That culture of self-interest and entitlement contrasts sharply with the cultural climate in medical research when the polio vaccine was developed.

67. GOVERNMENT & POLICY of Health Director harold E. varmus is getting any work done this summer. varmus cites the following advantages of Ebiomed, among others http://pubs.acs.org/hotartcl/cenear/990719/7729gov1.html

July 19, Volume 77, Number 29 CENEAR 77 29 pp. ISSN 0009-2347 VARMUS PUSHES HARD FOR E-BIOMED NIH director's online publishing proposal gets some kudos, but many commercial and scientific society publishers are up in arms Madeleine Jacobs I t's hard to believe National Institutes of Health Director Harold E. Varmus is getting any work done this summer. Ever since May 5, when he posted his idea for an electronic publishing site titled "E-biomed," the energetic Nobel Laureate has been getting an earful of comments from interested scientists, concerned commercial and nonprofit scientific publishers, and the scientific and general media. Varmus: forging ahead Varmus, of course, is not shy about giving as good as he gets, and that's just what he did late last month at two forums. The first was held at the National Academy of Sciences To understand why this proposal has riled so many people, one must first understand what Varmus has suggested in "E-biomed: A Proposal for Electronic Publications in the Biomedical Sciences" (http://www.nih.gov/welcome/director/ebiomed/ebiomed.htm).

68. Med.E.Mail Volume 7 E.Mail Index In This Issue APPOINTMENTS HONOURS AND AWARDS varmus TO VISIT will be delivered by Dr. harold E. varmus, Director, National Institutes of http://www.library.utoronto.ca/medicine/medemail/vol7/7number11.html

Faculty of Medicine News Med.E.Mail Volume 7 November 16, 1998. Volume 7, Number 11 Return to: [ Med.E.Mail Index In This Issue: APPOINTMENTS HONOURS AND AWARDS VARMUS TO VISIT THE FACULTY OF MEDICINE BROWN BAG ETHICS DISCUSSION DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY TEACHING AWARDS 1998-99 DECANAL PROMOTIONS COMMITTEE CANADA FOUNDATION FOR INNOVATION AWARDS MRC CLINICAL TRIALS GRANTS TEACHING OPPORTUNITY FOR POSTDOCTORAL FELLOWS APPOINTMENTS Lawrence Leiter (Department of Medicine) was elected to a two-year term as Chair of the Clinical and Scientific Section of the Canadian Diabetes Association (CDA) at the Annual Professional Conference of the CDA held in October 1998. David Sutton (Department of Medicine) has been elected Secretary of the World Apheresis Association, for a two-year term effective October 12, 1998. HONOURS AND AWARDS The Network Centre of Excellence program recently announced the formation of The Canadian Arthritis Network (CAN), funded for 4 years. Tony Cruz (Department of Laboratory Medicine and Pathobiology) is the Scientific Director of the CAN. Sandeep Naik (postgraduate trainee, Department of Medical Imaging, supervisors - Anthony Hanbidge and Stephanie Wilson) was awarded the CAR Benefactors' Prize at the Resident Awards Session of the Canadian Association of Radiologists 61st Annual Scientific Meeting held in June 1998 in Halifax, Nova Scotia. His presentation was entitled "Radiology Reports: a prospective study examining radiologist and clinician preference regarding style and content".

69. [EAS]Harold Varmus Redux EASharold varmus Redux. pjk pjk@design.eng.yale.edu 18 Dec 2002 034541 0500.Previous message EASHomeland Security; Next message EASRetro http://jove.eng.yale.edu/pipermail/eas-info/2002/000552.html

[EAS]Harold Varmus Redux pjk pjk@design.eng.yale.edu 18 Dec 2002 03:45:41 -0500 Previous message: [EAS]Homeland Security Next message: [EAS]Retro Attitudes Messages sorted by: [ date ] [ thread ] [ subject ] [ author ] Subject: Harold Varmus Redux Dear Colleagues - http://www.nytimes.com/2002/12/17/science/17JOUR.html?8bhp This NYT article announces an new project, headed by Harold Varmus, Nobel laureate and president of the Memorial Sloan-Kettering Cancer Center, "the creation of two peer-reviewed online journals on biology and medicine, with the goal of cornering the best scientific papers and immediately depositing them in the public domain." Brave e-publishing undertakings have had advocates for some time, like Stevan Harnad < http://www.ecs.soton.ac.uk/info/people/harnad > who said in 1995: "If from this day forward, everyone were to make available on the Net, in publicly accessible archives on the World Wide Web, the texts of all their current papers (and whichever past ones are still sitting on their word processors' disks) then the transition to the PostGutenberg Galaxy would happen virtually overnight." Harnad is founder/editor of an electronic preprint archive in the cognitive sciences < http://research.ecs.soton.ac.uk/projects/CogPrints.html

70. HHMI's BioInteractive - Donald E. Ganem, M.D. Donald E. Ganem, MD. While other kids parents were reading them tales of Peter Ganem asked harold varmus, then a professor of microbiology at UCSF (now http://www.hhmi.org/biointeractive/disease/ganem.html

Related Stories: Related Stories: Leprosy Malaria Polio B. Brett Finlay, Ph.D. Donald E. Ganem, M.D. While other kids' parents were reading them tales of Peter Rabbit and Robinson Crusoe, Don Ganem's father read bedside stories to him from the Encyclopaedia Britannica . "I discovered the joy of knowing things at a fairly early age," says Ganem. "Especially things other people didn't know. So I developed an addiction to facts. And if you're brought up with a fact addiction, science is a natural choice for a career." Still, it wasn't always clear that Ganem was headed for a career in biomedical research. In eighth grade, for example, he got an F in algebra because "I was holding hands with a girl in class," he says. "I wasn't paying very much attention to y=mx+b." In high school biology, however, he learned that researchers were figuring out how specific molecules perform critical jobs inside cells, and slowly his interests began to veer in that direction. "To think you could understand life at that level was quite mesmerizing," he adds. Diseases first captured Ganem's attention when he read The Microbe Hunters , Paul de Kruif's book about 18th and 19th-century medical scientists who tracked epidemics to their microbial origins. Impressed by the acumen and ingenuity these men demonstrated as they met immense challenges without the benefit of modern tools, Ganem quickly adopted these medical scientists as his heroes. During his senior year of high school, his parents gave him an 800-page medical microbiology text for Christmas. Undaunted by its length, Ganem looked on this tome as a fantastic treat. "The idea that there was that much to know I found really cool," he says. "This seemed like a field you could really sink your teeth into."

71. The Remarkable Transformation Of E-Biomed Into PubMed Central We also note that harold varmus, who set up the online EBiomed forum to gatherresponses from a broadly defined biomedical community, was surprised that so http://www.slis.indiana.edu/CSI/WP/wp01-03B.html

No. WP- 01-03 The Remarkable Transformation of E-Biomed into PubMed Central PDF Rob Kling *, Joanna Fortuna and Adam King *Center for Social Informatics SLIS Indiana University Bloomington, IN 47405 www.slis.indiana.edu/CSI Version 4.41 B-2 This is a working draft: we would appreciate your comments ABSTRACT INTRODUCTION The scientific publishing system is undergoing many small changes and several major transformations by relying increasingly upon digital media and the Internet. One major development was the creation of an electronic repository of technical reports (called e-prints) for some physics and mathematics fields, operated by the U.S. Department of Defenses’ Los Alamos National Laboratory (LANL). This repository, ArXiv.org, does not charge authors or readers for using it. Authors decide when to post their articles, and most of the posted articles are not peer-reviewed before they are posted (although the vast majority are eventually published in peer-reviewed journals or peer-reviewed conference proceedings). ArXiv.org was initiated in 1991, by April 5, 1998, 72,497 articles were posted on ArXiv.org [1]. The ArXiv.org model has been so successful that some observers suggest that scientists in every field should immediately adopt it (Harnad, 1999) One scientific field currently venturing into online scholarly publishing is biomedicine. As early as 1995 (Laporte, et al.), observers forecast the imminent “death of biomedical journals” and their replacement with electronically accessible biomedical information servers. Ongoing problems made this “electronic revolution” in biomedical publishing seem inevitable: large lag times between the submission and eventual publication of articles in biomedical journals frustrated researchers. The already high costs of printing, purchasing, and archiving traditional paper biomedical journals were rising well above the rate of inflation. Finally, many researchers felt that the limited range of publications accepted by major biomedical journals was stifling innovative research. Traditional biomedical journals have been described as a “19th Century Compromise” or a “Faustian bargain,” violating the primary goals of biomedical research rather than supporting them (Markovitz, 1998).

72. Gordon And Betty Moore Foundation The PLoS initiative has been led by Dr. harold E. varmus, president of theMemorialSloan Kettering Cancer Center, former director of the National http://www.moore.org/news/2002/news_pr_121702plos.asp

Our Staff Board of Trustees Financial Info Employment ... News News Public Library of Science to Launch New Free-Access Biomedical Journals with $9 Million Grant from the Gordon and Betty Moore Foundation December 17, 2002 CONTACT: Adrienne Larkin Phone: (650)724-4304 Fax: 415-358-4761 Email: plos@publiclibraryofscience.org Website: http://www.publiclibraryofscience.org San Francisco, CA, December 17, 2002 The Public Library of Science (PLoS), a non-profit, international grass-roots organization of scientists, announced today that it is launching a new scientific publishing venture that will make the published results of scientific research more accessible and useful to scientists, physicians and the public. This new effort is backed by a five-year, $9 million grant from the Gordon and Betty Moore Foundation and by an important policy decision from the Howard Hughes Medical Institute. The PLoS initiative has been led by Dr. Harold E. Varmus, president of the Memorial-Sloan Kettering Cancer Center, former director of the National Institutes of Health and 1989 Nobel Laureate; Dr. Patrick O. Brown of the Howard Hughes Medical Institute and Stanford University; and Dr. Michael B. Eisen of Lawrence Orlando Berkeley National Laboratory and the University of California, Berkeley. PLoS will publish two new journals - PLoS Biology and PLoS Medicine. The senior editorial board of the new journals is an international group of scientific luminaries (see list below). The PLoS journals will retain all of the important features of scientific journals, including rigorous peer-review and high editorial standards, but will use a new business model in which the costs of these services are recovered by modest fees on each published paper. This new model will allow PLoS to make all published works immediately available online, with no charges for access or restrictions on subsequent redistribution or use.

73. Varmus, Tsongas Speak At Whitehead Dedication - MIT News Office week at a ceremony that featured NIH Director and Nobel laureate harold E.varmus and former Senator Paul E. Tsongas, chairman of the board for Whitehead. http://web.mit.edu/newsoffice/1996/varmus-1002.html

Skip to content massachusetts institute of technology news office advanced search news recent research campus by topic ... archives services request images subscribe submit news promote news ... media inquiries about us news office info MIT background contact Varmus, Tsongas speak at Whitehead dedication October 2, 1996 The new wing of the Whitehead Institute for Biomedical Research was formally dedicated this week at a ceremony that featured NIH Director and Nobel laureate Harold E. Varmus and former Senator Paul E. Tsongas, chairman of the board for Whitehead. "This new facility, located at the heart of the biotechnology enterprise in Massachusetts, will allow Whitehead scientists to accelerate programs in cancer research, human genetics, AIDS and TB research, and basic developmental biology," said Mr. Tsongas. "Whitehead researchers are exploring the origins of disease at the molecular level and creating entirely new strategies for developing drugs and vaccines. They are laying the foundation for medicine in the 21st century." In his keynote address, Dr. Varmus outlined the reasons behind the Whitehead's success: "the strong linkage to MIT, a place that offers not only prestigious and wonderful students, but access to many disciplines-computer science, mathematics, engineering, chemistry, and physics-that are increasingly important for biomedical research. Second, the Institute's starting lineup of major investigators, people with both enthusiasm and prowess. Third, the inspiration it received at its inception from Jack Whitehead's generosity and from David Baltimore's leadership, and has received thereafter from its many advisors and of course, the current director, Gerry Fink.

74. E-Books (New!)Besides Coffin, John M.; Hughes, Stephen H.; varmus, harold E. Plainview (NY) Cold SpringHarbor Laboratory Press; c1997. Sequence Evolution - Function http://www.rug.nl/bibliotheek/locaties/bibCMB/!find?id=5039873¶ms=lang=en

75. FASEB Newsletter, September 1996 Harvard commencement address by NIH Director harold varmus. NIH Director haroldvarmus gave the commencement address at Harvard University earlier this year http://www.faseb.org/opa/newsletter/sep96/sep96x5.htm

Varmus Returns to Harvard Harvard commencement address by NIH Director Harold Varmus NIH Director Harold Varmus gave the commencement address at Harvard University earlier this year. (He received a M.A. in English literature from Harvard in 1962.) His commencement address presents an engaging perspective on his early career, the role that NIH played in his scientific research, and his thoughts on the pace of progress in medical research. An excerpt from his Harvard commencement address follows: I too had trouble settling on a career. While my fellow pre-meds worked late in their labs, I was editing the Amherst College paper and writing about Charles Dickens. In a prolonged adolescence as a Harvard graduate student, I read Beowulf, Shakespeare, and Sir Thomas Browne, and listened to Bill Alfred, Harry Levin, and Anne Ferry. Finally I went to medical school - in part, because someone once told Gertrude Stein that it "opened all doors," in part because medical students seemed more eager than I was to get out of bed in the morning. Like many physician-scientists of my generation, I learned to do and to love research while working at the National Institutes of Health, the Federal agency that supports most of the basic medical research in this country. I arrived at the NIH as a twenty-eight year-old doctor seeking two things: the credentials to become a medical school professor and an alternative to service in Vietnam. Then, one day some months later, I was abruptly transformed into a committed scientist, when a method I was developing to detect expression of a gene suddenly worked. The technique was not especially novel, and the questions I was asking were of interest only to a few people in the world. But, at that moment, I knew the intoxicating power of measurement and the sweet anticipation of my own results.

76. Varmus Presents His E-biomed Proposal To FASEB’s Publications Committee varmus Presents His Ebiomed Proposal to FASEB’s Publications Committee. On June2, NIH Director harold varmus spoke to the FASEB Publications and http://www.faseb.org/opa/newsletter/aug99/ebiomed.html

Varmus Presents His E-biomed Proposal to FASEB’s Publications Committee On June 2, NIH Director Harold Varmus spoke to the FASEB Publications and Communications Committee about his "E-biomed" proposal, a plan to develop a central, comprehensive, publicly accessible on-line database of scientific articles. Accompanied by David Lipman, head of the National Center for Biotechnology Information and contributing author of the E-biomed proposal, Varmus reviewed the details of the proposal and answered a variety of questions posed by the members of FASEB’s Publications Com-mittee. He began his discussion by placing it in the context of the on-going revolution in publishing, suggesting that this was time for action by those who wanted to shape it. According to Varmus’ plan, E-BIOMED: A Proposal for Electronic Publications in the Biomedical Sciences , "E-biomed is intended to be a new and more effective means to organize, disseminate, use, and store the information and ideas generated by the international biomedical research community. We envision a system for electronic publication in which existing journals, newly created journals, and an essentially unrestricted collection of scientific reports can be accessed and searched with great ease and without cost by anyone connected to the Internet. In a sense, what we are proposing is an electronic public library of medicine and other life sciences. Journals that participate in the E-biomed system would be expected to exercise expert review and editing functions. The NIH, in conjunction with other organizations, would contribute technical expertise, participate in the development of the governance of the system, and help with financial support." (For full text of the E-biomed proposal, see

77. Support Content For: E-Biomed Idea June 1999 Letter to NIH Director varmus regarding E-Biomed June 11, 1999. Dr.harold E. varmus National Institutes of Health One Center Drive http://www.asbmb.org/ASBMB/site.nsf/0/7A29F2F92008EA7585256C7C00535A7B?OpenDocum

78. IMSR 2.0.3 - Summary Results UN, Tg(Wnt1)1Hev, transgene insertion 1, harold E varmus, transgene insertion 1,harold E varmus. FVB/NJTg(Wnt1)1Hev/J JAX http://www.informatics.jax.org/imsr/fetch?page=imsrSummary&op:gsymname==&gsymnam

79. Sito Web Italiano Per La Filosofia-HAROLD E. VARMUS Translate this page harold E. varmus Sempre più spesso movimenti politici e autorità religiosechiedono di mettere limiti alla sperimentazione http://lgxserver.uniba.it/lei/rassegna/varmus.htm

INDICE DEI NOMI HAROLD E. VARMUS L'Unita' 30 AGOSTO 2001 P> nel lavoro degli scienziati di PIETRO GRECO L'Unita' 7 LUGLIO 2001 Chi ha paura della scienza? di PIETRO GRECO Il manifesto 10 GIUGNO 2001 Il divario digitale di MICHELE FABBRI

80. HHS/ASL Congressional Testimonies CY1997 June 10, 1997 harold varmus, Richard Klausner, Claude Lenfant, Samuel H.Wilson, Charles E. Leasure, Jr., Laurie Johnson, harold varmus (NIH), http://www.hhs.gov/asl/1997.html

skip navigational links This is an archive page. The links are no longer being updated. Calendar Year 1997 Congressional Testimonies Testimony Given at House Appropriations Hearings: FY 1998 Budget List November 13, 1997 The Honorable Donna E. Shalala (HHS) Subject: Prevention of Teen Smoking Before: House Committee on Commerce November 5, 1997 William F. Bensonb(AoA) Subject: Elderly Abuse in Nursing Homes Before: Older Americans Caucus, U.S. House of Representatives October 9, 1997 Harold Varmus (NIH) Subject: The Value of Clinical Research Before: Senate Committee on Labor and Human Resources, Subcommittee on Public Health and Safety October 1, 1997 Richard Klausner (NIH) Subject: Thyroid Exposure Received from Iodine-131 Before: Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education and Related Agencies September 30, 1997 Harold Varmus (NIH) Subject: NIH Research on Human Biology and Disease Before: House Committee on Commerce, Subcommittee on Health and the Environment September 29, 1997 Bruce Merlin Fried (HCFA)

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 99    Back | 1  | 2  | 3  | 4  | 5  | Next 20